Cognitive Behavior Therapy for Insomnia in Primary Care
- Conditions
- Insomnia
- Registration Number
- NCT01655797
- Lead Sponsor
- Uppsala University
- Brief Summary
The aim of this study was to investigate the clinical effectiveness of protocol-driven cognitive behavioral therapy (CBT) for insomnia delivered by ordinary primary care personnel (primary care nurses and social workers) in general medical practice with unselected patients, in line with a stepped care approach. The study design was a randomised controlled parallel group design, with allocation to CBT and waiting list control group (WL). Following an active treatment-control period, the control group were re-assigned to CBT. The study hypothesis was that the CBT group would experience less symptoms of insomnia after treatment compared with the WL group. Primary outcome measure was a brief self-report screening form, Insomnia severity index.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 66
- Fulfilled research criteria for chronic insomnia
- other untreated sleep disturbance
- pregnancy
- shift work
- concurrent medical or psychiatric condition that could be negatively affected by the treatment
- drug abuse
- severe depression
- dementia
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Change from baseline in the Insomnia severity index (ISI) After 9 weeks A brief self-report screening form
- Secondary Outcome Measures
Name Time Method Change from baseline in sleep quality (SQ) After 18 months Subjective sleep quality (likert scale)
Change from baseline in the fatigue severity scale (FSS) After 18 months Self-report questionnaire
Change from baseline in sleep-onset latency (SOL) After 18 months Time to fall asleep, measured with sleep diary
Change from baseline in wake time after sleep onset (WASO) After 18 months Time awake during the night, measured with sleep diary
Change from baseline in number of awakenings during the night (NWAK) After 18 months Measured with sleep diary
Change from baseline in Sleep efficiency (SE) After 18 months Time actually spent sleeping out of the total time in bed (%), measured with sleep diary
Change from baseline in time in bed (TIB) After 18 months Measured with sleep diary
Change from baseline in total sleep time (TST) After 18 months Measured with sleep diary
Change from baseline in the MOS 36-item short-form health survey, SF-36 After 18 months Questionnaire assessing physical and mental health
Change from baseline in the Hospital anxiety and depression scale, HADS After 18 months Self-report questionnaire measuring depression and anxiety
Change from baseline in the Epworth sleepiness scale, ESS After 18 moths Self-report questionnaire assessing daytime sleepiness
Change form baseline in the Pittsburgh sleep quality index (PSQI) After 18 months Self-report form assessing sleep quality
Change from baseline in the Minimal insomnia severity scale, MISS After 18 months Ultra short screening questionnaire for insomnia
Change from baseline in the Insomnia acceptance questionnaire, IQA After 18 months A questionnaire intended to assess acceptance of insomnia
Change from baseline in Body mass index After 18 months Change from baseline in sagittal abdominal diameter After 18 months Abdominal height (cm)
Change from baseline in waist-hip ratio After 18 months A ratio of the circumference of the waist to the hips
Change from baseline in blood pressure After 18 months Change from baseline in heart rate After 18 months Change from baseline in ALAT After 18 months Liver function
Change from baseline in HbA 1c After 18 months Glycated hemoglobin
Change from baseline in blood glucose After 18 months Change from baseline in triglycerides After 18 months A type of fat found in the blood
Change from baseline in cholesterol (LDL/HDL) After 18 months Change from baseline in the Insomnia severity index (ISI) After 18 months A brief self-report screening form
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Uppsala University
🇸🇪Uppsala, Sweden
Uppsala University🇸🇪Uppsala, Sweden